168 results on '"Hwang, Dong-Jin"'
Search Results
2. Advances in the understanding of androgen receptor structure and function and in the development of next-generation AR-targeted therapeutics
3. Identification of a targetable JAK-STAT enriched androgen receptor and androgen receptor splice variant positive triple-negative breast cancer subtype
4. DJ-X-013 ameliorates inflammation by reducing TNF-α/NF-κB expression and experimental colitis by inducing myeloid-derived suppressor cells
5. Data from Novel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate Cancer
6. Data from A Potent, Metabolically Stable Tubulin Inhibitor Targets the Colchicine Binding Site and Overcomes Taxane Resistance
7. Table S1 from A Potent, Metabolically Stable Tubulin Inhibitor Targets the Colchicine Binding Site and Overcomes Taxane Resistance
8. Supplementary Figures and Tables from Orally Bioavailable Androgen Receptor Degrader, Potential Next-Generation Therapeutic for Enzalutamide-Resistant Prostate Cancer
9. Figure S1 from A Potent, Metabolically Stable Tubulin Inhibitor Targets the Colchicine Binding Site and Overcomes Taxane Resistance
10. Supporting Figures S1-S4 from Novel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate Cancer
11. Supplementary Methods from Orally Bioavailable Androgen Receptor Degrader, Potential Next-Generation Therapeutic for Enzalutamide-Resistant Prostate Cancer
12. Metabolism-Guided Selective Androgen Receptor Antagonists: Design, Synthesis, and Biological Evaluation for Activity against Enzalutamide-Resistant Prostate Cancer
13. Inhibiting androgen receptor splice variants with cysteine-selective irreversible covalent inhibitors to treat prostate cancer
14. Abandoned babies: the backlash of South Korea's Special Adoption Act.
15. Structural and Functional Evidence for Testosterone Activation of GPRC6A in Peripheral Tissues
16. The Relationship Between International Students’ SNS Use and Their Life Satisfaction: Focusing on the Mediating Effects of Acculturation Stress
17. Exploration and Biological Evaluation of Basic Heteromonocyclic Propanamide Derivatives as SARDs for the Treatment of Enzalutamide-Resistant Prostate Cancer
18. Abstract 1235: Selective androgen receptor degraders for the treatment of androgen receptor-positive, triple-negative breast cancer
19. Discovery of first-in-class mitogen activated protein kinase (MAPK) 8–10 activator for the treatment of high grade serous ovarian cancer (1287)
20. Highly selective activator of Jun N-terminal kinase (JNK) for treatment of endometrioid ovarian carcinoma (1272)
21. A novel bis-indole destabilizes microtubules and displays potent in vitro and in vivo antitumor activity in prostate cancer
22. An Overview of Next-Generation Androgen Receptor-Targeted Therapeutics in Development for the Treatment of Prostate Cancer
23. Arylisothiocyanato selective androgen receptor modulators (SARMs) for prostate cancer
24. HIV-1 integrase inhibitory phenylpropanoid glycosides fromClerodendron trichotomum
25. Pyrazol-1-yl-propanamides as SARD and Pan-Antagonists for the Treatment of Enzalutamide-Resistant Prostate Cancer
26. Effects of a Novel Selective Androgen Receptor Modulator on Dexamethasone-Induced and Hypogonadism-Induced Muscle Atrophy
27. Abstract B037: Potential next-generation androgen receptor-targeted therapeutic for enzalutamide-resistant prostate cancer;In vivocharacterization in immune-compromised SRG rats
28. Preclinical Characterization of a (S)-N-(4-Cyano-3-Trifluoromethyl-Phenyl)-3-(3-Fluoro, 4-Chlorophenoxy)-2-Hydroxy-2-Methyl-Propanamide: A Selective Androgen Receptor Modulator for Hormonal Male Contraception
29. In Vitro and in Vivo Structure-Activity Relationships of Novel Androgen Receptor Ligands with Multiple Substituents in the B-Ring
30. HIV-1 integrase inhibitory phenylpropanoid glycosides from Clerodendron trichotomum
31. Orally Bioavailable Androgen Receptor Degrader, Potential Next-Generation Therapeutic for Enzalutamide-Resistant Prostate Cancer
32. Colchicine Binding Site Agent DJ95 Overcomes Drug Resistance and Exhibits Antitumor Efficacy
33. Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy
34. New Generation of Selective Androgen Receptor Degraders: Our Initial Design, Synthesis, and Biological Evaluation of New Compounds with Enzalutamide-Resistant Prostate Cancer Activity
35. Computationally identified novel agonists for GPRC6A
36. A Potent, Metabolically Stable Tubulin Inhibitor Targets the Colchicine Binding Site and Overcomes Taxane Resistance
37. Novel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate Cancer
38. Abstract 3223: Novel tubulin inhibitor DJ101 targets the colchicine binding site and suppresses melanoma growth and metastasis
39. MP57-03 IDENTIFICATION AND CHARACTERIZATION OF SELECTIVE ANDROGEN RECEPTOR DEGRADERS (SARDS) FOR THE TREATMENT OF ENZALUTAMIDE UNRESPONSIVE AND/OR RESISTANT PROSTATE CANCER
40. New Generation of Selective Androgen Receptor Degraders: Our Initial Design, Synthesis, and Biological Evaluation of New Compounds with Enzalutamide-Resistant Prostate Cancer Activity.
41. Current Advances of Tubulin Inhibitors in Nanoparticle Drug Delivery and Vascular Disruption/Angiogenesis
42. LB-S&T-06 NOVEL DUAL-BINDING SELECTIVE DEGRADERS OF FULL LENGTH AND SPLICE VARIANT ANDROGEN RECEPTORS FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER
43. Structural Optimization of Indole Derivatives Acting at Colchicine Binding Site as Potential Anticancer Agents
44. Anthrax toxin lethal factor domain 3 is highly mobile and responsive to ligand binding
45. Effect of B-ring substitution pattern on binding mode of propionamide selective androgen receptor modulators
46. I-387, a Novel Antimitotic Indole, Displays a Potent In vitro and In vivo Antitumor Activity with Less Neurotoxicity
47. Effects of a Novel Selective Androgen Receptor Modulator on Dexamethasone-Induced and Hypogonadism-Induced Muscle Atrophy
48. ChemInform Abstract: Synthesis of Cyclopentene-Fused Pyrroloisoquinolinone Derivative via N-Acyliminium Ion Cyclization.
49. Nonsteroidal Selective Androgen Receptor Modulators Enhance Female Sexual Motivation
50. A novel bis-indole destabilizes microtubules and displays potent in vitro and in vivo antitumor activity in prostate cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.